Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Wedzicha (London, United Kingdom). Challenges in COPD exacerbations and future research and unknowns. Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention

Member's Comments

Alejandro Videla - 21.07.2014 15:14
excellent

Related content which might interest you: Is there a need for pharmacoepidemiology in asthma and COPD? Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials Year: 2004 What is a COPD exacerbation? Current definitions, pitfalls, challenges and opportunities for improvement Source: Eur Respir J, 52 (5) 1801261; 10.1183/13993003.01261-2018 Year: 2018 It is time to further expand research in tailoring self-management of COPD exacerbations! Source: Eur Respir J, 55 (1) 1902225; 10.1183/13993003.02225-2019 Year: 2020 Measuring and quantifying acute exacerbations of COPD: pitfalls and practicalities Source: Eur Respir J 2014; 43: 662-664 Year: 2014 COPD - Current challenges Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge Year: 2008 Clinical clustering of COPD patients is useful to predict future COPD exacerbations Source: International Congress 2018 – New predictors of morbidity and mortality in COPD Year: 2018 The healthcare burden of non-compliance to pharmacotherapeutic escalation recommendations for COPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Therapeutic options for COPD exacerbations Source: International Congress 2014 – PG04 Update on COPD exacerbations Year: 2014 Translating mechanisms to new drugs for COPD exacerbations Source: Annual Congress 2009 - LANCET/ERS symposium: “Evolving dimensions of COPD” Year: 2009 Mathematical model to predict the risk of future exacerbations in non-smoking patients with COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 The future of personalised medicine in COPD Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease Year: 2016 Methodologies for study of COPD exacerbations Source: Annual Congress 2012 - ERS COPD exacerbation guidelines: methodologies and overview Year: 2012 Recommendations of new therapies for severe asthma and the future Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma Year: 2013 Validation of the recording of acute exacerbations of COPD in the clinical practice research datalink: Phase 1 results Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 The future of COPD treatment: what are the difficulties in and barriers to drug development for COPD Source: Annual Congress 2011 - Lancet / ERS symposium - New frontiers in COPD Year: 2011 ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions Source: Guideline 2019 Year: 2019